Hippocratic AI raises $141M, valued at $1.6B
Hippocratic AI, a company developing a generative artificial intelligence for healthcare providers, has closed a $141 million Series B funding round.
The company is valued at $1.6 billion as part of the funding round.
Related: Top digital health funding: ICHRA-focused startup gets $100M
Venture capital firm Kleiner Perkins led the round. Other investors included venture capital firms Andreessen Horowitz, General Catalyst, technology company Nvidia and provider organizations such as York, Pennsylvania-based WellSpan Health and for-profit hospital system Universal Health Services.
Hippocratic AI is developing a generative AI model that aims to help providers complete non-diagnostic and patient-facing tasks. The funding will be used to expand its focus to use cases to assist pharma and payers. The company also said the capital would help it expand to other regions outside of North America.
The round brings the company’s total raised to $278 million.
Evergreen Nephrology nabs $130M
Evergreen Nephrology, a value-based kidney care company, closed a $130 million funding round.
Healthcare investment firm Rubicon Founders, venture capital firm Oak HC/FT and a group of unnamed existing investors led the round with participation from K2 HealthVentures.
The company provides clinical, technical, and financial support to nephrologists including offering the assistance of additional care team members such as care coordinators, social workers, dietitians and pharmacists. Evergreen said it would use the funding for geographic expansion and to invest in new technology.
The company operates in 24 states with a network of over 900 providers. Last year, the company inked a deal for Humana's Medicare Advantage members in 17 states to access its services.
Kaiser Permanente leads $275M Innovaccer funding round
Oakland, California-based Kaiser Permanente led a $275 million Series F funding round for Innovaccer, a company that sells technology to unify patient data across health systems. Read more.
Qualified Health launches with $30M in seed funding
Qualified Health, a generative AI company, closed a $30 million seed funding round.
Initial investors include venture capital firms SignalFire, Healthier Capital, Town Hall Ventures and Frist Cressey Ventures. Salt Lake City-based Intermountain Health and venture capital firm Flare Capital Partners also participated in the round.
The company plans to sell a platform that aims to help health systems develop an infrastructure to implement and scale generative AI tools. Qualified said it would use the funding to build its engineering team.
CVS, Optum invest in Nema Health
Nema Health, a virtual mental health company focused on trauma and post-traumatic stress disorder, closed a $14.5 million Series A funding round.
Investment firm Deerfield Management led the round. CVS Health Ventures, the venture arm of the retail giant, and participated along with existing investors including Optum Ventures, .406 Ventures and GreyMatter.
The company uses virtual clinicians to help patients understand how to interpret trauma and how the trauma affects their feelings and behavior. Nema also offers patients the ability to connect with other trauma survivors for peer-to-peer support. The company operates in eight states and will use the funding to scale and broaden insurance coverage.
The round brings Nema’s total raised to $18.6 million, according to a spokesperson.
Red Rover Health closes $4M seed round
Red Rover Health, a technology platform company focused on integrating tools from third-party developers, secured $4 million in a seed funding round.
Investment firm NewShore Partners was the sole investor in the round.
The company sells third-party software vendors a platform aiming to help them interface with electronic health records. Red Rover works with EHRs from companies including Epic, Oracle, Athenahealth and Meditech. The company will use the funds to scale.
